BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 24606655)

  • 1. [A multicenter study on the validation of conversion factor for the conversion of BCR-ABL (P210) transcript levels to the international scale in chronic myeloid leukemia].
    Qin Y; Lin Z; Cen J; Li X; Li Q; Cheng H; Geng S; Wang Y; Ma D; Qiao C; Li J; Li L; Huang X
    Zhonghua Xue Ye Xue Za Zhi; 2014 Feb; 35(2):134-7. PubMed ID: 24606655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A multicenter comparison study on the quantitative detection of bcr-abl (P210) transcript levels in China].
    Qin YZ; Cheng H; Cen JN; Geng SX; Li QH; Li XQ; Lin ZX; Ma DX; Qiao C; Wang YG; Li JL; Li LD; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):104-8. PubMed ID: 23611214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A multicenter study on the revalidation of validated conversion factor for the conversion of BCRABL(P210)transcript levels to the international scale in chronic myeloid leukemia].
    Qin Y; Ma D; Wang Y; Wang L; Wang Y; Liu S; Lu X; Li X; Cen J; Xiao M; Lin Z; Geng S; Liang C; Chen H; Han C; Han W; Huang X
    Zhonghua Xue Ye Xue Za Zhi; 2015 Oct; 36(10):814-7. PubMed ID: 26477757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency of BCR-ABL fusion transcripts in Iranian patients with chronic myeloid leukemia.
    Yaghmaie M; Ghaffari SH; Ghavamzadeh A; Alimoghaddam K; Jahani M; Mousavi SA; Irvani M; Bahar B; Bibordi I
    Arch Iran Med; 2008 May; 11(3):247-51. PubMed ID: 18426313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Overexpression of Shp-2 is associated with the unlimited growth and apoptosis resistance of p210 bcr-abl-mediated chronic myeloid leukemia].
    Zhu XZ; Yu YZ; Fang YM; Liang Y; Lü QH; Xu RZ
    Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1903-6. PubMed ID: 16255985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The influence of peripheral blood sample storage and delivery on the quantitative detection result of BCR-ABL (P210) transcript levels].
    Hua MQ; He N; Zhong CQ; Yang XY; Liu JT; Wang RQ; Han FJ; Zhang C; Ma DX
    Zhonghua Xue Ye Xue Za Zhi; 2021 Mar; 42(3):224-229. PubMed ID: 33910308
    [No Abstract]   [Full Text] [Related]  

  • 7. [Standardization of quantitative detection of BCR-ABL gene expression by RQ-PCR in patients with chronic myeloid leukemia in cooperation with European Leukemia Net].
    Sacha T; Zawada M; Czekalska S; Florek I; Mueller M; Gniot M; Jaźwiec B; Kyrcz-Krzemień S; Leszczyńska A; Lewandowski K; Matiakowska K; Solarska I; Stokłosa T; Skotnicki AB
    Przegl Lek; 2010; 67(7):454-9. PubMed ID: 21387754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of p210 and p190 BCR-ABL due to alternative splicing in chronic myelogenous leukaemia.
    Lichty BD; Keating A; Callum J; Yee K; Croxford R; Corpus G; Nwachukwu B; Kim P; Guo J; Kamel-Reid S
    Br J Haematol; 1998 Dec; 103(3):711-5. PubMed ID: 9858221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion, correction, and International Scale standardization: results From a Multicenter External Quality Assessment Study for BCR-ABL1 testing.
    Griffiths M; Patton SJ; Grossi A; Clark J; Paz MF; Labourier E;
    Arch Pathol Lab Med; 2015 Apr; 139(4):522-9. PubMed ID: 25061833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the «BCR/ABL - multitest» kit in the algorithm of laboratory diagnostics of oncohematological diseases: economic aspects.
    Gorbenko AS; Stolyar MA; Vasiliev EV; Mikhalev MA; Bakhtina VI; Olkhovik TI; Mochalova EE; Orlova KE; Olkhovskiy IA
    Klin Lab Diagn; 2021 Sep; 66(9):571-576. PubMed ID: 34543537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of BCR-ABL fusion transcripts in Sudanese patients with chronic myeloid leukemia using real-time reverse transcription-polymerase chain reaction.
    Muddathir AM; Kordofani AA; Fadl-Elmula IM
    Saudi Med J; 2013 Jan; 34(1):29-33. PubMed ID: 23299156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive analysis of BCR/ABL variants in chronic myeloid leukemia patients using multiplex RT-PCR.
    Bennour A; Ouahchi I; Moez M; Elloumi M; Khelif A; Saad A; Sennana H
    Clin Lab; 2012; 58(5-6):433-9. PubMed ID: 22783572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harmonization of molecular monitoring of chronic myeloid leukemia therapy in Japan.
    Yoshida C; Fletcher L; Ohashi K; Wakita H; Kumagai T; Shiseki M; Matsuei K; Inokuchi K; Hatta Y; Shirasugi Y; Yamaguchi T; Sakamoto J; Branford S; Sakamaki H
    Int J Clin Oncol; 2012 Dec; 17(6):584-9. PubMed ID: 21986632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bcr-Abl has a greater intrinsic capacity than v-Abl to induce the neoplastic expansion of myeloid cells.
    Gross AW; Ren R
    Oncogene; 2000 Dec; 19(54):6286-96. PubMed ID: 11175343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative real-time RT-PCR monitoring of BCR-ABL in chronic myelogenous leukemia shows lack of agreement in blood and bone marrow samples.
    Stock W; Yu D; Karrison T; Sher D; Stone RM; Larson RA; Bloomfield CD
    Int J Oncol; 2006 May; 28(5):1099-103. PubMed ID: 16596225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-time quantitative reverse transcriptase polymerase chain reaction.
    Fan H; Robetorye RS
    Methods Mol Biol; 2010; 630():199-213. PubMed ID: 20300999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International reporting scale of BCR-ABL1 fusion transcript in chronic myeloid leukemia: first report from India.
    Balasubramanian P; Chendamarai E; Markose P; Fletcher L; Branford S; George B; Mathews V; Chandy M; Srivastava A
    Acta Haematol; 2012; 127(3):135-42. PubMed ID: 22249155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense inhibition of P210 bcr-abl in chronic myeloid leukemia.
    Vaerman JL; Lewalle P; Martiat P
    Stem Cells; 1993 Oct; 11 Suppl 3():89-95. PubMed ID: 8298481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purging of chronic myelogenous leukemia cells by retrovirally expressed anti-bcr-abl ribozymes with specific cellular compartmentalization.
    Mendoza-Maldonado R; Zentilin L; Fanin R; Giacca M
    Cancer Gene Ther; 2002 Jan; 9(1):71-86. PubMed ID: 11916246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of bcr-abl transcript in chronic myelogenous leukemia patients by reverse-transcription-polymerase chain reaction and capillary electrophoresis.
    Martinelli G; Testoni N; Montefusco V; Amabile M; Saglio G; Ottaviani E; Terragna C; Bonifazzi F; de Vivo A; Pane F; Rosti G; Tura S
    Haematologica; 1998 Jul; 83(7):593-601. PubMed ID: 9718863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.